Skip to main content
. 2023 Jul 1;14(4):501–510. doi: 10.32598/bcn.2021.3122.1

Table 2.

CARS and ATEC scores of the patients in the three groups before and after intervention in addition to the percent change

Scale G1 (HBOT) G2 (Risperidone) G3 (Placebo)

Mean±SD % of scores changes P Mean±SD % P Mean±SD % P
CARS Before 36.2±1.47 −12.62 <0.001 34.85±1.9 −8.9 <0.001 33.45±2.33 −1.52 0.33
After 31.63±1.73 31.75±2.02 32.94±2.71
ATEC Before 67.82±4.21 −14.11 <0.001 73.31±3.72 −5.17 <0.001 71.6±3.02 −2.56 0.004
After 58.24±3.83 69.52±5.27 69.77±3.11
Speech Before 14.33±1.69 −15.28 <0.001 15.63±1.22 −11.64 <0.001 17.49±2 −5.61 0.02
After 12.14±1.71 13.81±2.22 16.51±1.97
Social Before 15.78±1.59 −3.42 0.07 16.92±1.73 0.83 0.76 14.47±1.42 −3.52 0.057
After 15.24±1.77 17.06±2.56 13.96±1.34
Cognition Before 16.82±2.36 −11.06 <0.001 18.71±1.09 −10.69 <0.001 18.89±1.45 0.58 0.71
After 14.96±2.07 16.71±2.19 19±1.53
Behavior Before 20.9±2.62 −23.92 <0.001 22.04±2.51 −0.45 0.838 20.75±1.56 −2.17 0.07
After 15.9±2.55 21.94±1.94 20.3±1.15

CARS: Childhood autism rating scale; ATEC: Autism treatment evaluation checklist.